Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Tekla Healthcare Investors (HQH : NYSE)

• Company Description    Tekla Healthcare Investors is a diversified closed-end management investment company. It primarily invests in the healthcare industry (including biotechnology, medical devices, and pharmaceuticals). The Fund's objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. Tekla Healthcare Investors, formerly known as H&Q Healthcare Investors, is based in Boston, Massachusetts. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $16.86 Daily Weekly Monthly 20 Day Moving Average: 134,183 shares Shares Outstanding: 46.34 (millions) Market Capitalization: $781.36 (millions) Beta: 0.86 52 Week High: $22.31 52 Week Low: $16.82 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -9.26% -8.01% 12 Week -5.76% -9.44% Year To Date -6.33% -8.65%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2 LIBERTY SQUARE 9TH FLOOR - BOSTON,MA 02109 USA ph: 617-772-8500 fax: 617-772-8577 info@teklacap.com http://www.teklacap.com

• General Corporate Information    Officers Daniel R. Omstead - President Laura Woodward - Treasurer and Secretary - - - - - - - - - Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: FIN-INVEST FUND Sector: Finance CUSIP: 87911J103 SIC: 6726 Fiscal Year Fiscal Year End: September Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 46.34 Most Recent Split Date: (:1) Beta: 0.86 Market Capitalization: $781.36 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 9.79% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $1.65 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 02/24/2023 - $0.42 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 12/31/22 - - 09/30/22 - - 06/30/22 - - ROA 12/31/22 - - 09/30/22 - - 06/30/22 - - Current Ratio 12/31/22 - - 09/30/22 - - 06/30/22 - - Quick Ratio 12/31/22 - - 09/30/22 - - 06/30/22 - - Operating Margin 12/31/22 - - 09/30/22 - - 06/30/22 - - Net Margin 12/31/22 - - 09/30/22 - - 06/30/22 - - Pre-Tax Margin 12/31/22 - - 09/30/22 - - 06/30/22 - - Book Value 12/31/22 - - 09/30/22 - - 06/30/22 - - Inventory Turnover 12/31/22 - - 09/30/22 - - 06/30/22 - - Debt-to-Equity 12/31/22 - - 09/30/22 - - 06/30/22 - - Debt-to-Capital 12/31/22 - - 09/30/22 - - 06/30/22 - -

Powered by Zacks Investment Research ©